Delcath Systems is an oncology-focused specialty pharmaceutical and medical device company. The Delcath Hepatic Delivery System, the company’s proprietary drug/device combination product, is designed to administer high-dose chemotherapy and other therapeutic agents to diseased organs or regions of the body – controlling the systemic exposure of those agents at the same time. Delcath’s initial focus is on treating primary and metastatic liver cancers. For more information, visit the company’s Web site: http://www.delcath.com
Let us hear your thoughts below: